{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:03:45Z","timestamp":1770044625472,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.beem.2006.07.005","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T12:09:23Z","timestamp":1158667763000},"page":"435-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Genetic basis of phaeochromocytoma and paraganglioma"],"prefix":"10.1016","volume":"20","author":[{"given":"Diana E.","family":"Benn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.07.005_bib1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM200205093461911","article-title":"Pheochromocytoma \u2013 death of an axiom","volume":"346","author":"Dluhy","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.005_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.07.005_bib3","first-page":"223","article-title":"Tumors of the adrenal gland and extra-adrenal paraganglia","author":"Lack","year":"1997"},{"key":"10.1016\/j.beem.2006.07.005_bib4","series-title":"World Health Organization International Histological Classification of Tumours","first-page":"38","article-title":"Histological typing of endocrine tumours","year":"2000"},{"key":"10.1016\/j.beem.2006.07.005_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/eje.1.01833","article-title":"Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas","volume":"152","author":"Van Houtum","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.07.005_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.beem.2006.07.005_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncpendmet0097","article-title":"The genetic basis of pheochromocytoma: who to screen and how?","volume":"2","author":"Plouin","year":"2006","journal-title":"Nature Clinical Practice. Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.005_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/humu.10092","article-title":"Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein","volume":"20","author":"Wautot","year":"2002","journal-title":"Human Mutation"},{"key":"10.1016\/j.beem.2006.07.005_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1385\/EP:14:4:329","article-title":"Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas","volume":"14","author":"Dannenberg","year":"2003","journal-title":"Endocrine Pathology"},{"key":"10.1016\/j.beem.2006.07.005_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.beem.2006.07.005_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/373536a0","article-title":"Catalytic specificity of protein-tyrosine kinases is critical for selective signalling","volume":"373","author":"Songyang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.beem.2006.07.005_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2006.07.005_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium","volume":"238","author":"Mulligan","year":"1995","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.beem.2006.07.005_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/eje.0.1440037","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study","volume":"144","author":"Nguyen","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.07.005_bib16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.beem.2006.07.005_bib17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib18","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.ghir.2004.03.033","article-title":"Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2)","volume":"14","author":"Jimenez","year":"2004","journal-title":"Growth Hormone & IGF Research"},{"key":"10.1016\/j.beem.2006.07.005_bib19","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"Machens","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von-Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.beem.2006.07.005_bib21","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.beem.2006.07.005_bib22","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1073\/pnas.96.22.12436","article-title":"Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex","volume":"96","author":"Iwai","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.beem.2006.07.005_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx 1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.beem.2006.07.005_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.beem.2006.07.005_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Hoffman","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib26","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.07.005_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.beem.2006.07.005_bib28","series-title":"Genetic Disorders of Endocrine Neoplasia. Frontiers of Hormone Research Series","first-page":"131","article-title":"von Hippel-Lindau disease: genetic and clinical observations","author":"Iliopoulos","year":"2001"},{"key":"10.1016\/j.beem.2006.07.005_bib29","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther","year":"1999","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.beem.2006.07.005_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.beem.2006.07.005_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib33","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/hmg\/ddi359","article-title":"Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions","volume":"14","author":"Briere","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1095-144","article-title":"Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency","volume":"11","author":"Bourgeron","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0079-6603(08)60895-8","article-title":"Molecular genetics of succinate: quinone oxidoreductase in eukaryotes","volume":"60","author":"Scheffler","year":"1998","journal-title":"Progress in Nucleic Acid Research and Molecular Biology"},{"key":"10.1016\/j.beem.2006.07.005_bib36","series-title":"Chemistry and Biochemistry of Flavoproteins","first-page":"229","article-title":"Structure and function of succinate dehydrogenase and fumarate reductase","author":"Ackrell","year":"1990"},{"key":"10.1016\/j.beem.2006.07.005_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0098-2997(02)00012-2","article-title":"Cytopathies involving mitochondrial complex II","volume":"23","author":"Ackrell","year":"2002","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.beem.2006.07.005_bib38","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/324413","article-title":"The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway","volume":"69","author":"Gimenez-Roqueplo","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"Lee","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2006.07.005_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2006.07.005_bib43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1737","article-title":"Mitochondrial tumour suppressors: a genetic and biochemical update","volume":"5","author":"Gottlieb","year":"2005","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000472358","article-title":"Further localization of the gene for hereditary paragangliomas (PGL), and evidence for linkage in unrelated families","volume":"2","author":"Heutink","year":"1994","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s004390050939","article-title":"Repositioning the hereditary paraganglioma critical region on chromosome band 11q23","volume":"104","author":"Baysal","year":"1999","journal-title":"Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib46","first-page":"6822","article-title":"Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma","volume":"60","author":"Gimm","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.beem.2006.07.005_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/gcc.1144","article-title":"Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene","volume":"31","author":"Taschner","year":"2001","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jmg.39.3.178","article-title":"Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas","volume":"39","author":"Baysal","year":"2002","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2265.2003.01914.x","article-title":"Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility","volume":"59","author":"Astuti","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2006.07.005_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2006.07.005_bib51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00439-003-0969-6","article-title":"Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect","volume":"113","author":"Astrom","year":"2003","journal-title":"Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib53","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1200\/JCO.2005.07.198","article-title":"Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD","volume":"23","author":"Dannenberg","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beem.2006.07.005_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ajmg.1270","article-title":"Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma","volume":"100","author":"Milunsky","year":"2001","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib55","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beem.2006.07.005_bib56","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1038\/sj.onc.1207591","article-title":"Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families","volume":"23","author":"Hensen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2006.07.005_bib57","first-page":"2061","article-title":"Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma","volume":"8","author":"Dannenberg","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.beem.2006.07.005_bib58","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1136\/jmg.2004.030353","article-title":"Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X","volume":"42","author":"Simi","year":"2005","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-2005-870156","article-title":"New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas","volume":"37","author":"Bertherat","year":"2005","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.beem.2006.07.005_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10689-004-4227-4","article-title":"Mutations of the SDHB and SDHD genes","volume":"4","author":"Pawlu","year":"2005","journal-title":"Familial Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib61","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1210\/jc.2004-0769","article-title":"Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma","volume":"89","author":"McWhinney","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/gcc.10212","article-title":"G12S and H50R variations are polymorphisms in the SDHD gene","volume":"37","author":"Cascon","year":"2003","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib63","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.onc.1206300","article-title":"Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas","volume":"22","author":"Benn","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2006.07.005_bib64","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.beem.2006.07.005_bib65","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2004-1398","article-title":"Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma","volume":"90","author":"Amar","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.cco.0000198017.45982.06","article-title":"Evolving concepts in pheochromocytoma and paraganglioma","volume":"18","author":"Dahia","year":"2006","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.beem.2006.07.005_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib68","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1651-2227.2004.tb00854.x","article-title":"Pheochromocytoma in childhood: implication for further diagnostic procedures","volume":"93","author":"Beck","year":"2004","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.beem.2006.07.005_bib69","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Schiavi","year":"2005","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2006.07.005_bib70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/jmg.2004.019224","article-title":"An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma","volume":"41","author":"Baysal","year":"2004","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10689-004-0621-1","article-title":"SDHC mutations in hereditary paraganglioma\/pheochromocytoma","volume":"4","author":"Muller","year":"2005","journal-title":"Familial Cancer"},{"key":"10.1016\/j.beem.2006.07.005_bib72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(05)70166-2","article-title":"Controversies and ethical issues in cancer-genetics clinics","volume":"6","author":"Harris","year":"2005","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.beem.2006.07.005_bib73","first-page":"53","article-title":"Ethical considerations in the use of DNA for the diagnosis of diseases","volume":"27","author":"Barlow-Stewart","year":"2006","journal-title":"The Clinical Biochemist. Review"},{"key":"10.1016\/j.beem.2006.07.005_bib74","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/thy.2005.15.140","article-title":"Inherited medullary thyroid cancer and the duty to warn: revisiting Pate v. Threlkel in light of HIPAA","volume":"15","author":"Rosenthal","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2006.07.005_bib75","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bmj.322.7293.1052","article-title":"The complexities of predictive genetic testing","volume":"322","author":"Evans","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2006.07.005_bib76","first-page":"4101","article-title":"Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene","volume":"82","author":"Brauch","year":"1997","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.005_bib77","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1038\/sj.onc.1205812","article-title":"Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients","volume":"21","author":"Perren","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2006.07.005_bib78","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1136\/jmg.2003.012658","article-title":"Genetic and epigenetic profile of sporadic pheochromocytomas","volume":"41","author":"Cascon","year":"2004","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.beem.2006.07.005_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jso.20177","article-title":"Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor","volume":"89","author":"Elder","year":"2005","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.beem.2006.07.005_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1445-5994.2006.01023.x","article-title":"An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years","volume":"36","author":"Elston","year":"2006","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.beem.2006.07.005_bib81","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jc.2005-2758","article-title":"Paraganglioma \u2013 all in the family","volume":"91","author":"Young","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:37:46Z","timestamp":1761496666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1521690X06000510"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.07.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic basis of phaeochromocytoma and paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}